跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
QUDIX PROLONG 600 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
QUDIX PROLONG 600 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA
Approved
STANDARD
QUDIX PROLONG 600 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA
Adamed Laboratorios S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 18, 2025
Approval ID
79d63445b703ffe8
Company
Adamed Laboratorios S.L.U.
Type
Standard
Approval Details
Approval Id
79d63445b703ffe8
Drug Cima Aemps Name
QUDIX PROLONG 600 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA
Register Number
90209
Holder Company Name
Adamed Laboratorios S.L.U.
Marketing Company Name
Adamed Laboratorios S.L.U.
Authorization Date
2025-03-18
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
600 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Adamed Laboratorios S.L.U.
Active Ingredients
QUETIAPINA FUMARATO
690,72 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 18, 2025
Approval ID
79d63445b703ffe8
Type
Standard
Back to CIMA-AEMPS Approvals